4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-104820
Chief Scientific Officer sold 8,000 shares at $18.09 ($144,720)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Michaelson Jennifer Chief Scientific Officer | 2024-09-05 | Sale 10b5-1 | −8,000 | $18.09 | $144,720 | 115,942 | D: show line 1 in the form |
| Open-market sales · 8,000 sh · avg $18.09 · $144,720 | |||||||
Loading xslF345X05/ownership.xml…